60 DEGREES PHARMACEUTICALS, INC. (SXTP) Insider Trading Disclosures
60 DEGREES PHARMACEUTICALS, INC. (SXTP) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SXTP
CIK: 1946563
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
RBSM LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerMARLENE HUTCHESON
Audit LocationLAS VEGAS, Nevada, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-06 | 2026-10-06 | CURRENT REPORT | 0001213900-26-106979 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-12 | CURRENT REPORT | 0001213900-26-099702 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-08 | CURRENT REPORT | 0001213900-26-098056 | View SEC Doc Filr Page |
| EFFECT | 2026-08-25 | — | EFFECT Filing | 9999999995-26-002759 | View SEC Doc Filr Page |
| DEL AM | 2026-08-17 | — | DELAYING AMENDMENT | 0001213900-26-090587 | View SEC Doc Filr Page |
| S-3 | 2026-08-14 | — | REGISTRATION STATEMENT | 0001213900-26-090125 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001554855-26-001860 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-05 | CURRENT REPORT | 0001213900-26-086136 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-05 | — | SCHEDULE 13G Filing | 0000929638-26-002891 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-07-30 | CURRENT REPORT | 0001213900-26-085235 | View SEC Doc Filr Page |
| 3 | 2026-07-29 | 2026-07-22 | 3 Filing | 0001213900-26-082796 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-29 | — | SCHEDULE 13G Filing | 0001213900-26-082794 | View SEC Doc Filr Page |
| 8-K | 2026-07-20 | 2026-07-20 | CURRENT REPORT | 0001213900-26-079612 | View SEC Doc Filr Page |
| 8-K | 2026-07-09 | 2026-07-07 | CURRENT REPORT | 0001213900-26-076715 | View SEC Doc Filr Page |
| DEF 14A | 2026-07-02 | 2026-08-05 | DEFINITIVE PROXY STATEMENT | 0001213900-26-074961 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-12 | 4 Filing | 0001213900-26-068853 | View SEC Doc Filr Page |
| PRE 14A | 2026-06-08 | 2026-06-08 | PRELIMINARY PROXY STATEMENT | 0001213900-26-066363 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-06-03 | CURRENT REPORT | 0001213900-26-064796 | View SEC Doc Filr Page |
| 3 | 2026-05-19 | 2026-05-13 | 3 Filing | 0001213900-26-059167 | View SEC Doc Filr Page |
| 8-K | 2026-05-18 | 2026-05-13 | CURRENT REPORT | 0001213900-26-058495 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001213900-26-057698 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001649553-26-000060 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001554855-26-001058 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-13 | — | SCHEDULE 13G/A Filing | 0001213900-26-055849 | View SEC Doc Filr Page |
| 10-K | 2026-03-30 | 2025-12-31 | 10-K | 0001554855-26-000467 | View SEC Doc Filr Page |